Concepedia

Publication | Open Access

Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation

DOIFull Paper Access

173

Citations

20

References

2018

Year

Rachna T. Shroff, Andrew Hendifar, Robert R. McWilliams, Ravit Geva, Ron Epelbaum, Lindsey Rolfe, Sandra Goble, Kevin Lin, Andrew V. Biankin, Heidi Giordano,
JCO Precision Oncology

Abstract

Rucaparib provided clinical benefit to patients with advanced pancreatic cancer and a <i>BRCA1/2</i> mutation, and demonstrated an acceptable safety profile. Additional trials of rucaparib in this population are warranted.

References

YearCitations

Page 1